Hot Pursuit     11-Mar-24
Zydus Lifesciences Ltd soars 1.52%, rises for fifth straight session
Zydus Lifesciences Ltd is quoting at Rs 991.55, up 1.52% on the day as on 12:44 IST on the NSE. The stock is up 112.69% in last one year as compared to a 30.64% spurt in NIFTY and a 66.62% spurt in the Nifty Pharma.

Zydus Lifesciences Ltd gained for a fifth straight session today. The stock is quoting at Rs 991.55, up 1.52% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is down around 0.37% on the day, quoting at 22411.2. The Sensex is at 73794.19, down 0.44%. Zydus Lifesciences Ltd has risen around 15.75% in last one month.

Meanwhile, Nifty Pharma index of which Zydus Lifesciences Ltd is a constituent, has risen around 3.5% in last one month and is currently quoting at 19194.1, up 0.67% on the day. The volume in the stock stood at 14.88 lakh shares today, compared to the daily average of 12.82 lakh shares in last one month.

The benchmark March futures contract for the stock is quoting at Rs 996.25, up 1.43% on the day. Zydus Lifesciences Ltd is up 112.69% in last one year as compared to a 30.64% spurt in NIFTY and a 66.62% spurt in the Nifty Pharma index.

The PE of the stock is 36.79 based on TTM earnings ending December 23.

Previous News
  Stock Alert: Zydus Lifesciences, Dr Reddy’s Lab, Shyam Metalics and Energy, KEC International
 ( Market Commentary - Stock Alert 26-Aug-24   08:31 )
  Sensex gains 239 pts; metal shares shine; VIX rallies 3.35%
 ( Market Commentary - Mid-Session 31-Jul-24   12:33 )
  Zydus Lifesciences Ltd soars 1.23%, gains for fifth straight session
 ( Hot Pursuit - 21-May-24   13:00 )
  Zydus Life rises on USFDA nod for dyskinesia treatment drug
 ( Hot Pursuit - 28-Aug-24   09:57 )
  Zydus Life hits record high on USFDA nod for chest pain prevention drug
 ( Hot Pursuit - 16-Feb-24   16:53 )
  Zydus Life gains on USFDA nod for prostatic hyperplasia drug
 ( Hot Pursuit - 18-Mar-24   09:40 )
  Zydus Lifesciences to declare Quarterly Result
 ( Corporate News - 31-Jan-24   12:07 )
  Zydus receives USFDA tentative approval for Edaravone Injection
 ( Corporate News - 14-Mar-24   13:51 )
  Zydus Lifesciences declare Quarterly Result
 ( Corporate News - 09-May-24   13:52 )
  Zydus enters into non-exclusive patent licensing agreement with Takeda
 ( Corporate News - 17-Jul-24   15:41 )
  Zydus receives USFDA approval for Plerixafor Injection
 ( Corporate News - 27-Jul-23   13:32 )
Other Stories
  RailTel Corporation bags order worth Rs 134.46-cr
  28-Sep-24   15:03
  Lupin’s Pithampur facility completes USFDA inspection with 3 observations
  28-Sep-24   14:54
  Zydus Life gets final approval from USFDA for cancer drug
  28-Sep-24   14:42
  Alembic Pharma’s Gujarat unit gets EIR from USFDA
  28-Sep-24   13:02
  Bajel Projects wins first data centre order
  28-Sep-24   12:11
  Oriental Rail Infra bags order worth Rs 1.79 cr
  28-Sep-24   10:43
  Avantel bags order worth Rs 44 cr from Larsen & Toubro
  28-Sep-24   10:09
  Kaushalya Logistics spurts on inking LoI with McDonald’s
  27-Sep-24   15:37
  Marsons hits the roof on bagging order worth Rs 675 cr
  27-Sep-24   15:27
  Rites bags order worth Rs 100-cr from Adani Ports & SEZ
  27-Sep-24   15:26
Back Top